(Q28609419)

https://api.crossref.org/works/10.1007%2FS11883-001-0061-4

The Asp9 Asn mutation in the lipoprotein lipase gene is associated with increased progression of coronary atherosclerosis. REGRESS Study Group, Interuniversity Cardiology Institute, Utrecht, The Netherlands. Regression Growth Evaluation Statin Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-001-0061-4

A common mutation in the lipoprotein lipase gene promoter, -93T/G, is associated with lower plasma triglyceride levels and increased promoter activity in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-001-0061-4

Ethnic variation and in vivo effects of the -93t-->g promoter variant in the lipoprotein lipase gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-001-0061-4

Common sequence variants of lipoprotein lipase: standardized studies of in vitro expression and catalytic function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-001-0061-4

ApoCIII gene variants modulate postprandial response to both glucose and fat tolerance tests.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-001-0061-4

Common genetic variation in the promoter of the human apo CIII gene abolishes regulation by insulin and may contribute to hypertriglyceridemia

21 January 2018

1 reference

12 December 2020

A common Hpa I RFLP of apolipoprotein C-I increases gene transcription and exhibits an ethnically distinct pattern of linkage disequilibrium with the alleles of apolipoprotein E.

1 reference

12 December 2020

Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies.

1 reference

12 December 2020

Modulation of plasma triglyceride levels by apoE phenotype: a meta-analysis

1 reference

12 December 2020

Two common mutations (D9N, N291S) in lipoprotein lipase: a cumulative analysis of their influence on plasma lipids and lipoproteins in men and women.

1 reference

12 December 2020

Relationship of glucose intolerance to coronary risk in Afro-Caribbeans compared with Europeans

1 reference

12 December 2020

Substitution of asparagine for aspartic acid at residue 9 (D9N) of lipoprotein lipase markedly augments risk of ischaemic heart disease in male smokers.

1 reference

12 December 2020

Severe hypertriglyceridemia, reduced high density lipoprotein, and neonatal death in lipoprotein lipase knockout mice. Mild hypertriglyceridemia with impaired very low density lipoprotein clearance in heterozygotes

1 reference

12 December 2020

A mutation in the human lipoprotein lipase gene as the most common cause of familial chylomicronemia in French Canadians

1 reference

12 December 2020

Remnant lipoprotein metabolism: key pathways involving cell-surface heparan sulfate proteoglycans and apolipoprotein E

1 reference

12 December 2020

Association between the LPL-D9N mutation in the lipoprotein lipase gene and plasma lipid traits in myocardial infarction survivors from the ECTIM study

1 reference

12 December 2020

Overexpression of apolipoprotein CII causes hypertriglyceridemia in transgenic mice

1 reference

12 December 2020

Lipoprotein lipase mutations, plasma lipids and lipoproteins, and risk of ischemic heart disease. A meta-analysis

1 reference

12 December 2020

Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells

1 reference

12 December 2020

The Asn9 variant of lipoprotein lipase is associated with the -93G promoter mutation and an increased risk of coronary artery disease

1 reference

12 December 2020

Modulation of lipoprotein lipase activity by apolipoproteins. Effect of apolipoprotein C-III

1 reference

12 December 2020

Type III hyperlipoproteinemic phenotype in transgenic mice expressing dysfunctional apolipoprotein E.

1 reference

12 December 2020

Variation at the apo AI/CIII/AIV gene complex is associated with elevated plasma levels of apo CIII

1 reference

12 December 2020

Alteration of lipid profiles in plasma of transgenic mice expressing human lipoprotein lipase.

1 reference

12 December 2020

Targeted disruption of the apolipoprotein C-III gene in mice results in hypotriglyceridemia and protection from postprandial hypertriglyceridemia

1 reference

12 December 2020

An apolipoprotein CIII haplotype protective against hypertriglyceridemia is specified by promoter and 3' untranslated region polymorphisms

1 reference

12 December 2020

The insulin resistance syndrome and postprandial lipid intolerance in smokers.

1 reference

12 December 2020

Mechanism of hypertriglyceridemia in human apolipoprotein (apo) CIII transgenic mice. Diminished very low density lipoprotein fractional catabolic rate associated with increased apo CIII and reduced apo E on the particles

1 reference

12 December 2020

Increased response to cholesterol feeding in apolipoprotein C1-deficient mice

1 reference

12 December 2020

Lipoprotein lipase enhances the binding of chylomicrons to low density lipoprotein receptor-related protein

1 reference

12 December 2020

Apolipoprotein C-III gene variation and dyslipidaemia

1 reference

12 December 2020

Interaction of the lipoprotein lipase asparagine 291-->serine mutation with body mass index determines elevated plasma triacylglycerol concentrations: a study in hyperlipidemic subjects, myocardial infarction survivors, and healthy adults.

1 reference

12 December 2020

Lipoprotein lipase gene variants and risk of coronary disease: a quantitative analysis of population-based studies

1 reference

12 December 2020

Common variation in the lipoprotein lipase gene: effects on plasma lipids and risk of atherosclerosis.

1 reference

12 December 2020

Evidence for the role of hepatic endothelial lipase in the metabolism of plasma high density lipoprotein2 in man.

1 reference

12 December 2020

The multifunctional role of hormone-sensitive lipase in lipid metabolism

1 reference

12 December 2020

Characterization of the lipid-binding properties and lipoprotein lipase inhibition of a novel apolipoprotein C-III variant Ala23Thr

1 reference

12 December 2020

Induced mutant mouse lines that express lipoprotein lipase in cardiac muscle, but not in skeletal muscle and adipose tissue, have normal plasma triglyceride and high-density lipoprotein-cholesterol levels

1 reference

12 December 2020

Black-white differences in postprandial triglyceride response and postheparin lipoprotein lipase and hepatic triglyceride lipase among young men.

1 reference

12 December 2020

Contribution of apolipoprotein C-III gene variants to determination of triglyceride levels and interaction with smoking in middle-aged men

1 reference

12 December 2020

Combined hyperlipidemia in transgenic mice overexpressing human apolipoprotein Cl

1 reference

12 December 2020

DNA POLYMORPHISM ADJACENT TO HUMAN APOPROTEIN A-1 GENE: RELATION TO HYPERTRIGLYCERIDAEMIA

1 reference

12 December 2020

Familial lipoprotein lipase (LPL) deficiency: A catalogue of LPL gene mutations identified in 20 patients from the UK, Sweden, and Italy

1 reference

12 December 2020

Triglyceride lipases and atherosclerosis.

1 reference

12 December 2020

Atherogenic, dense low-density lipoproteins. Pathophysiology and new therapeutic approaches

1 reference

12 December 2020

Apolipoprotein C-I modulates the interaction of apolipoprotein E with beta-migrating very low density lipoproteins (beta-VLDL) and inhibits binding of beta-VLDL to low density lipoprotein receptor-related protein

1 reference

12 December 2020